Friday, 16 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 12, 2026

Earnings live: Cisco stock drops after outlook disappoints, AppLovin sinks, Equinix surges

View original at finance.yahoo.com
Earnings live: Cisco stock drops after outlook disappoints, AppLovin sinks, Equinix surges The fourth quarter earnings season is more than halfway over, and the S&P 500 is on track for solid earnings growth…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Mattel achieved strong topline growth in Q4 with positive consumer demand in every region, but December US gross billings grew less than expected

    80% confidence

  • Robinhood aims to become a Financial SuperApp through banking services, stock tokens, crypto trading, and event contracts

    80% confidence

  • Wall Street analysts estimate 13% EPS growth for S&P 500 Q4 2025, up from initial 8.3% expectation

    80% confidence

  • Vertiv expects data center market momentum to continue in 2026 with record backlog providing clear visibility into another year of significant growth

    80% confidence

  • Cisco sees strong, broad-based demand for technology solutions and remains focused on capturing significant opportunities ahead

    80% confidence

  • Kraft Heinz challenges are fixable and within company's control

    80% confidence

  • $600 million investment across marketing, sales, R&D and pricing will accelerate return to profitable growth

    80% confidence

  • Marriott is seeing a K-shaped economic bifurcation of consumers with consistent strength in luxury segment throughout the year

    80% confidence

Data points we hold from this source

Ford Motor Company · net loss-8 billion_USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com
Earnings live: Cisco stock drops after outlook disappoints, AppLovin sinks, Equinix surges — Source | Via News | ViaNews EU